Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.10 -0.15 (-4.77%)
As of: Oct 22, 2026 · 3:57 PM EDT

Apimeds Pharmaceuticals US (APUS) Other Non Operating Income (2025 - 2026)

Updated

Apimeds Pharmaceuticals US's Other Non Operating Income was $282,989 in Q2 2026, compared with -$9,518 a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Other Non Operating Income (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Apimeds Pharmaceuticals US's Other Non Operating Income was $260,612 through Jun 30, 2026; for FY2025, it came in at -$22,377.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Apimeds Pharmaceuticals US 5.39 Mn -14.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 283,447.00
Dec 31, 2025 -424.00
Sep 30, 2025 -12,859.00
Jun 30, 2025 -9,518.00
API Access

Apimeds Pharmaceuticals US Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=APUS&period=max&api_key=YOUR_API_KEY